Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Clinical trial NCT03865212 · TERMINATED

Trial details

NCT number: NCT03865212
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Metastatic Choroid Melanoma Metastatic Melanoma Metastatic Mucosal Melanoma Metastatic Uveal Melanoma Pathologic Stage III Cutaneous Melanoma AJCC v8 Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Pathologic Stage IV Cutaneous Melanoma AJCC v8

Start date: 2019-06-12
Primary completion: 2025-10-12
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.